Health Catalyst, Inc. (HCAT)

NMS – Real vaqt narxi. Valyuta: USD

1.79

+0.03 (1.70%)

Yopilishda: Aug 12, 2026, 4:00 PM EDT

1.79

0.00 (0.00%)

Bozordan keyin: Aug 12, 2026, 4:15 PM EDT

07.08.2026

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.

07.08.2026

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

06.08.2026

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

06.08.2026

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.04 per share a year ago.

06.08.2026

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance. SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026.

06.08.2026

Health Catalyst Reports Second Quarter 2026 Results

SALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. “We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said Ben Albert, Chief Executive Officer of Health Catalyst.

Videolar

No Data

There is no data to display

Press-relizlar

06.08.2026

Health Catalyst, Inc. (HCAT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Health Catalyst, Inc. (HCAT)

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results

Videolar

No Data

Press-relizlar

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results

Videolar

No Data

Press-relizlar

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results

Search stocks

Health Catalyst, Inc. (HCAT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Health Catalyst, Inc. (HCAT)

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results

Videolar

No Data

Press-relizlar

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Q2 Earnings Call Highlights

Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results

Videolar

No Data

Press-relizlar

Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company

Health Catalyst Reports Second Quarter 2026 Results